An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program

OBJECTIVE: To examine the efficacy and safety of fenfluramine in patients with Dravet syndrome (DS) in three age groups: <6, 6‐17, and ≥18 years old, treated in a real‐world setting. METHODS: Patients with DS were treated with fenfluramine in the European Union Early Access Program (EAP). Followi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrini, Renzo, Specchio, Nicola, Aledo‐Serrano, Ángel, Pringsheim, Milka, Darra, Francesca, Mayer, Thomas, Gil‐Nagel, Antonio, Polster, Tilman, Zuberi, Sameer M., Lothe, Amélie, Gammaitoni, Arnold, Strzelczyk, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712464/
https://www.ncbi.nlm.nih.gov/pubmed/35801621
http://dx.doi.org/10.1002/epi4.12624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712464/
https://www.ncbi.nlm.nih.gov/pubmed/35801621
http://dx.doi.org/10.1002/epi4.12624

Ejemplares similares